TrianecT

TrianecT is a startup with a mission to get stroke patients to the right hospital for the right treatment as fast as possible. With 10 million severe stroke patients picked up by ambulances annually, the company aims to address the issue of these patients being brought to hospitals that do not have endovascular treatment. This results in an average delay of endovascular treatment of 90 minutes, leading to worsened outcomes and a larger societal burden. The solution offered by TrianecT involves the combination of brain activity measurement and artificial intelligence to detect treatable stroke patients in the ambulance and bring them directly to their best treatment. By doing so, the company aims to save crucial time as it equates to saving brain function. Operating in the Health Care and Medical Devices industries, the startup was founded in 2022. However, specific details regarding headquarters, last investment, and investors are currently not available. The innovative approach of TrianecT to address the critical issue of stroke patient treatment presents an interesting opportunity for potential investors and stakeholders in the healthcare sector.